Home
Our Approach
Investment Banking
Case Studies
Management Team
Historical Clients
Contact Us

Case Study: Oscient Pharmaceuticals Corp.

LSG supported Company transition from genomics discovery to a specialty pharma/anti-infective focused organization

  • Our Firm worked with Company management to substantially revise the corporate presentation to reflect the Company’s new strategy
  • LSG raised $13.5MM in a PIPE transaction from recognized institutional investors
  • LSG subsequently acted as sole advisor in Oscient’s $200MM acquisition of GeneSoft
  • Our Firm was also co-advisor of a $90MM registered direct offering by Oscient  

© 2008 Life Science Group. All Rights Reserved

For more information visit: http://www.finra.org
This web-site is not in any sense a solicitation or offer of the purchase or sale of securities. The statements herein are made without any representation as to the accuracy or completeness or otherwise. Life Science Group Inc. is registered to conduct securities transactions in CA, CT, DE, FL, IL, KY, MD, MA, MI, NJ, NY, NC, OR, SC,TX, WA, WV,WI.
 
 
Website design & development by Starting Line Design - For more information click here